CY1118870T1 - Θειο-υποκατεστημενα διαρυλ-μεθανοσουλφινυλ παραγωγα - Google Patents

Θειο-υποκατεστημενα διαρυλ-μεθανοσουλφινυλ παραγωγα

Info

Publication number
CY1118870T1
CY1118870T1 CY20171100334T CY171100334T CY1118870T1 CY 1118870 T1 CY1118870 T1 CY 1118870T1 CY 20171100334 T CY20171100334 T CY 20171100334T CY 171100334 T CY171100334 T CY 171100334T CY 1118870 T1 CY1118870 T1 CY 1118870T1
Authority
CY
Cyprus
Prior art keywords
methanesulfinyl
sulfur
derivative
substituted diaryl
disease
Prior art date
Application number
CY20171100334T
Other languages
English (en)
Inventor
Edward R Bacon
Sankar Chatterjee
Derek Dunn
Marie-Edith Gourdel
Greg A Hostetler
Mohamed Iqbal
Brigitte Lesur
Philippe Louvet
Dominique Schweizer
Christophe Yue
Eric Riguet
Original Assignee
Cephalon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290982A external-priority patent/EP1586559A1/en
Application filed by Cephalon, Inc. filed Critical Cephalon, Inc.
Publication of CY1118870T1 publication Critical patent/CY1118870T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/10—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε χημικές συνθέσεις, μεθόδους για την παρασκευή αυτών και χρήσεις της σύνθεσης. Ιδιαιτέρως, η παρούσα εφεύρεση αφορά σε συνθέσεις που περιλαμβάνουν υποκατεστημένα διαρυλ-μεθανοσουλφινύλ ακεταμίδια του Τύπου (I): όπου Αr, Υ, R1, R2, R4, R5, q και x είναι όπως ορίζονται στο παρόν· και χρήση αυτών στη θεραπεία ασθενειών, που συμπεριλαμβάνουν θεραπεία υπνηλίας που συνδυάζεται με ναρκοληψία, αποφρακτική άπνοια ύπνου, ή διαταραχή εργασίας με βάρδιες· ασθένεια Parkinson· ασθένεια Alzheimer· διαταραχή ελλειμματικής προσοχής· διαταραχή ελλειμματικής προσοχής υπερδραστικότητας· κατάθλιψη· ή κόπωση που συνδυάζεται με νευρολογική νόσο· καθώς επίσης την προαγωγή εγρήγορσης.
CY20171100334T 2004-04-13 2017-03-16 Θειο-υποκατεστημενα διαρυλ-μεθανοσουλφινυλ παραγωγα CY1118870T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04290982A EP1586559A1 (en) 2004-04-13 2004-04-13 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
US56915304P 2004-05-07 2004-05-07
US11/104,091 US7449481B2 (en) 2004-04-13 2005-04-12 Thio-substituted biaryl-methanesulfinyl derivatives
PCT/US2005/012836 WO2005100308A1 (en) 2004-04-13 2005-04-13 Thio-substituted biaryl-methanesulfinyl derivatives
EP05735327.8A EP1737815B1 (en) 2004-04-13 2005-04-13 Thio-substituted biaryl-methanesulfinyl derivatives

Publications (1)

Publication Number Publication Date
CY1118870T1 true CY1118870T1 (el) 2018-01-10

Family

ID=34965682

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100334T CY1118870T1 (el) 2004-04-13 2017-03-16 Θειο-υποκατεστημενα διαρυλ-μεθανοσουλφινυλ παραγωγα

Country Status (18)

Country Link
US (2) US7449481B2 (el)
EP (1) EP1737815B1 (el)
JP (1) JP4859828B2 (el)
AU (1) AU2005233195B2 (el)
CA (1) CA2561897C (el)
CY (1) CY1118870T1 (el)
DK (1) DK1737815T3 (el)
ES (1) ES2619844T3 (el)
HK (1) HK1095808A1 (el)
HR (1) HRP20170441T1 (el)
HU (1) HUE031853T2 (el)
LT (1) LT1737815T (el)
MX (1) MXPA06011836A (el)
NZ (1) NZ550555A (el)
PL (1) PL1737815T3 (el)
PT (1) PT1737815T (el)
RS (1) RS55795B1 (el)
WO (1) WO2005100308A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7297817B2 (en) 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
EP1702915A1 (en) * 2005-03-14 2006-09-20 Cephalon France Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
WO2012040511A2 (en) * 2010-09-22 2012-03-29 Calcimedica, Inc. Compounds that modulate intracellular calcium
CA2989243C (en) 2014-08-13 2023-03-14 Red Bull Gmbh Heterocyclic compounds with working memory enhancing activity
PL2985279T3 (pl) 2014-08-13 2018-03-30 Red Bull Gmbh Związki heterocykliczne mające działanie poprawiające pamięć roboczą

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US3689567A (en) 1966-08-01 1972-09-05 Tsung Ying Shen Benzyl methyl sulfones and process for preparing same
US3637803A (en) * 1969-05-22 1972-01-25 Merck & Co Inc Alkyl methylsulfonylalkyl benzoates
US3894034A (en) 1973-01-29 1975-07-08 Ohio State Res Found A process for producing azasulfonium salts
AT336589B (de) 1974-05-20 1977-05-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen biphenylderivaten
DE2545947A1 (de) 1975-10-14 1977-04-28 Thomae Gmbh Dr K Verfahren zur herstellung von optisch aktiven sulfoxiden
GB1520812A (en) 1975-10-02 1978-08-09 Lafon Labor Benzhydrylsulphinyl derivatives
DE2546319C2 (de) 1975-10-16 1986-02-27 Dr. Karl Thomae Gmbh, 7950 Biberach Cyclohexylphenyl-Derivate, Verfahren zu deren Herstellung und diese enthaltende Mittel
GB1570982A (en) 1976-03-05 1980-07-09 Shell Int Research Substituted benzyl ethers and thioethers
US4050921A (en) 1976-04-16 1977-09-27 Uniroyal Inc. Regulation of the natural growth or development of plants with 2-sulfinyl or 2-sulfonyl pyridine N-oxide compounds
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
US4162973A (en) * 1977-06-02 1979-07-31 Afl Industries, Inc. Water polishing system
US4216160A (en) 1977-10-25 1980-08-05 Merck & Co., Inc. Substituted mercapto acid amides and their use
AU4091178A (en) 1977-10-25 1980-04-24 Merck & Co Inc Substituted mercapto acid amides
GB1600840A (en) 1978-05-30 1981-10-21 Wellcome Found Diphenylether derivatives useful as flukicidal agents
US4329363A (en) 1978-09-08 1982-05-11 Merck & Co., Inc. Substituted mercapto acid amides and their use
DE3100387A1 (de) 1981-01-09 1982-09-02 Basf Ag, 6700 Ludwigshafen Substituierte diphenylether, diese enthaltende herbizide und ihre anwendung als herbizide
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
US5105017A (en) 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
IT1201113B (it) 1986-01-10 1989-01-27 Fmc Corp Composti erbicidi
US4846882A (en) 1986-01-10 1989-07-11 Fmc Corporation Herbicidal aryl tetrahydrophthalimides
FR2593809B1 (fr) 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
IL82657A0 (en) 1986-06-03 1987-11-30 Rhone Poulenc Agrochimie N-(5-substituted methylene)phenyl herbicides
DE3872937T2 (de) 1987-05-11 1993-01-21 Ono Pharmaceutical Co Benzoylaminophenoxybuttersaeure-derivate.
DE3851262T2 (de) 1987-06-04 1995-02-02 Ono Pharmaceutical Co Benzoylaminophenoxybuttersäure-Derivate.
US4846875A (en) 1987-07-21 1989-07-11 Fmc Corporation Herbicidal triazolinones
GB8801300D0 (en) 1988-01-21 1988-02-17 May & Baker Ltd New compositions of matter
GB9010404D0 (en) 1990-05-09 1990-06-27 Pfizer Ltd Therapeutic agents
FR2663225B1 (fr) 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
JPH0459754A (ja) 1990-06-28 1992-02-26 Fujirebio Inc アミド誘導体
JP2872359B2 (ja) * 1990-06-29 1999-03-17 株式会社ブリヂストン 非帯電性ポリウレタン樹脂の製造方法
EP0473549B1 (de) 1990-08-28 1995-01-25 Ciba-Geigy Ag Sulfoxide von Alkylthiomethylphenolen
FR2684875B1 (fr) 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
JPH063546A (ja) * 1992-06-18 1994-01-14 Ibiden Co Ltd シングルモード光導波路
FR2697162B1 (fr) 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (el) 1993-06-22 1995-09-08 Lafon Labor
FR2707637B1 (fr) 1993-06-30 1995-10-06 Lafon Labor Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique.
FR2708201B1 (fr) 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5585359A (en) 1994-09-29 1996-12-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
DE69514604T2 (de) 1994-10-04 2000-06-21 Aventis Research & Technologies Gmbh & Co Kg Verfahren zur Herstellung von Polymeren aus Alpha, Omega ungesättigten konjugierten Verbindungen
US5675017A (en) * 1995-06-07 1997-10-07 Monsanto Company Herbicidal substituted 3-aryl-pyrazoles
DE19541146A1 (de) * 1995-10-25 1997-04-30 Schering Ag Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren
US5744339A (en) 1996-08-30 1998-04-28 Cephalon, Inc. Thiomethylene group-containing aldehyde cysteine and serine protease inhibitors
GB9624817D0 (en) 1996-11-28 1997-01-15 British Biotech Pharm Metalloproteinase inhibitors
US5760246A (en) 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
JP3989102B2 (ja) * 1997-10-02 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 縮合ピリジン誘導体
FR2771004B1 (fr) 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
AU2298599A (en) * 1998-02-04 1999-08-23 Nissan Chemical Industries Ltd. Pyridine derivatives fused with azole and herbicide
JP2000281664A (ja) * 1999-03-30 2000-10-10 Otsuka Pharmaceut Co Ltd チアゾール誘導体
EP1167382A1 (en) 1999-03-31 2002-01-02 Otsuka Pharmaceutical Co., Ltd. Influenza virus hemagglutinin-binding peptides
US6346548B1 (en) 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
MXPA02002873A (es) 1999-09-16 2002-08-30 Axys Pharm Inc Compuestos y composiciones farmaceuticas como inhibidores de la catepsina s.
EP1274697A1 (en) 2000-02-21 2003-01-15 AstraZeneca AB Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
JP2002201178A (ja) * 2000-07-17 2002-07-16 Takeda Chem Ind Ltd スルホン誘導体、その製造法及び用途
CZ2003529A3 (cs) 2000-07-27 2003-09-17 Teva Pharmaceutical Industries Ltd. Krystalický a čistý modafinil a postup jeho přípravy
WO2002040431A2 (en) * 2000-11-17 2002-05-23 Dow Agrosciences Llc Compounds having fungicidal activity and processes to make and use same
US7157463B2 (en) * 2001-01-23 2007-01-02 Eli Lilly And Company Substituted piperidines/piperazines as melanocortin receptor agonists
US7012075B2 (en) 2001-03-02 2006-03-14 Merck & Co., Inc. Cathepsin cysteine protease inhibitors
AU2002247208A1 (en) 2001-03-05 2002-09-19 Icos Corporation Selective pde3b inhibitors and use of the same in therapy
RU2003130271A (ru) * 2001-03-14 2005-02-27 Е.И.Дюпон де Немур энд Компани (US) Усовершенствованные способы орто-алкилирования
US6958328B2 (en) * 2001-04-18 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc Arylindenopyridines and related therapeutic and prophylactic methods
AU2002257459B2 (en) * 2001-05-24 2006-12-14 Merck Frosst Canada Ltd 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
NZ530051A (en) 2001-06-12 2006-12-22 Wellstat Therapeutics Corp Polycyclic oxy-aromatic acid derivatives for the treatment of metabolic disorders
CN1723196A (zh) 2001-06-27 2006-01-18 史密丝克莱恩比彻姆公司 作为二肽酶抑制剂的氟代吡咯烷
US7653490B2 (en) 2001-09-10 2010-01-26 Triad Liquidating Company LLC Nuclear magnetic resonance assembly of chemical entities
ATE338036T1 (de) 2002-02-22 2006-09-15 Bayer Pharmaceuticals Corp Zur behandlung hyperproliferativer erkrankungen geeignete benzofuran- und benzothiophenderivate
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives

Also Published As

Publication number Publication date
NZ550555A (en) 2010-10-29
US20090062284A1 (en) 2009-03-05
EP1737815B1 (en) 2016-12-21
WO2005100308A1 (en) 2005-10-27
HK1095808A1 (zh) 2007-05-18
EP1737815A1 (en) 2007-01-03
JP4859828B2 (ja) 2012-01-25
AU2005233195A1 (en) 2005-10-27
JP2008505058A (ja) 2008-02-21
HUE031853T2 (en) 2017-08-28
ES2619844T3 (es) 2017-06-27
CA2561897A1 (en) 2005-10-27
US7449481B2 (en) 2008-11-11
CA2561897C (en) 2013-05-28
AU2005233195B2 (en) 2012-04-19
MXPA06011836A (es) 2007-05-04
PT1737815T (pt) 2017-04-03
PL1737815T3 (pl) 2017-06-30
US7981907B2 (en) 2011-07-19
LT1737815T (lt) 2017-04-25
DK1737815T3 (en) 2017-02-06
RS55795B1 (sr) 2017-08-31
HRP20170441T1 (hr) 2017-05-19
US20050245747A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CY1118870T1 (el) Θειο-υποκατεστημενα διαρυλ-μεθανοσουλφινυλ παραγωγα
CY1123507T1 (el) Ετεροκυκλικη ενωση και χρηση αυτης ως θετικος σε υποδοχεα αμρα αλλοστερικος τροποποιητης
CY1118472T1 (el) Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
CY1117726T1 (el) Θετικοι αλλοστερικοι ρυθμιστες υποδοχεα μ1 κινολιναμιδιου
ATE475650T1 (de) Positive allosterische chinolon-m1- rezeptormodulatoren
CY1114329T1 (el) Νεοι προσδετες υποδοχεων αδενοσινης και χρησεις εξ' αυτων
ATE524439T1 (de) Thiosubstituierte arylmethansulfinylderivate
EA201170705A1 (ru) Арилметилбензохиназолиноны в качестве позитивных аллостерических модуляторов рецептора м1
NO20025508D0 (no) Substituerte tioacetamider
MY153979A (en) Substituted piperidino-dihydrothienopyrimidine
ATE530544T1 (de) Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren
EA201100921A1 (ru) Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
ATE548032T1 (de) Verwendung von chlorguanabenzderivaten zur behandlung von mit polyglutaminexpansion assoziierten erkrankungen
EA201070903A1 (ru) Замещенные спироциклические производные пиперидина как лиганды гистамин-3(h) рецептора
MX2010005563A (es) Preparacion de terpolimeros cationicos y composiciones para el cuidado personal.
ATE452134T1 (de) Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
IL205045A (en) Piperidinyl and piperazine derivatives, preparations containing them and their uses
ATE552257T1 (de) Positive allosterische chinolizidinon-m1- rezeptormodulatoren
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
ATE552251T1 (de) Thiophen- und furanverbindungen
BRPI0509448A (pt) métodos para a formação de uma folha não trançada estirável, folhas não trançadas estiráveis, vestimenta de higiene pessoal e vestimenta
EA201070494A1 (ru) МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ С АМИДНЫМИ СВЯЗЯМИ
MX2010004311A (es) Productos intermedios de moduladores de gamma-secretasa.